615
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions

, , , , , , , & show all
Pages 541-549 | Received 18 Oct 2006, Accepted 08 Feb 2007, Published online: 04 Oct 2008

Figures & data

Figure 1 Structures of chimanine B, previously synthesized 4-(E)-pentenylpyrrolo[1,2-a]quinoxalines and new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines 1a–m.

Figure 1 Structures of chimanine B, previously synthesized 4-(E)-pentenylpyrrolo[1,2-a]quinoxalines and new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines 1a–m.

Scheme 1 Synthesis of 4-(E)-alkenylpyrrolo[1,2-a]quinoxaline derivatives 1a–m. Reagents and conditions: (i) DMTHF, AcOH, Δ; (ii) CuSO4, NaBH4, EtOH, RT; (iii) CO(OCCl3)2, toluene, Δ; (iv) POCl3, Δ; (v) Method A: CH3(CH2)3CH = CH-B(O-C(CH3)2-)2, KOH; Pd[P(C6H5)3]4, C6H6, Δ; Method B: CH3(CH2)4-6CH = CH-B(OH)2, Pd[P(C6H5)3]4, Na2CO3, C6H6, EtOH, Δ.; Method C: CH3(CH2)7CH = CH-BF3K, PdCl2(dppf)·CH2Cl2, Cs2CO3, THF-H2O, Δ.

Scheme 1 Synthesis of 4-(E)-alkenylpyrrolo[1,2-a]quinoxaline derivatives 1a–m. Reagents and conditions: (i) DMTHF, AcOH, Δ; (ii) CuSO4, NaBH4, EtOH, RT; (iii) CO(OCCl3)2, toluene, Δ; (iv) POCl3, Δ; (v) Method A: CH3(CH2)3CH = CH-B(O-C(CH3)2-)2, KOH; Pd[P(C6H5)3]4, C6H6, Δ; Method B: CH3(CH2)4-6CH = CH-B(OH)2, Pd[P(C6H5)3]4, Na2CO3, C6H6, EtOH, Δ.; Method C: CH3(CH2)7CH = CH-BF3K, PdCl2(dppf)·CH2Cl2, Cs2CO3, THF-H2O, Δ.

Table I.  Physical properties of 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines 1a–m.

Table II.  In vitro sensitivity of compounds 1a–m on L. amazonensis and L infantum strains, and cytotoxicity on human peripheral blood mononuclear cells PBMNC + PHA.

Figure 2 Log D / activity relationship for pyrrolo[1,2-a]quinoxalines 1a–m L. amazonensis and L. infantum strains.

Figure 2 Log D / activity relationship for pyrrolo[1,2-a]quinoxalines 1a–m L. amazonensis and L. infantum strains.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.